Title:
OPHTHALMIC COMPOSITION COMPRISING BRIMONIDINE
Document Type and Number:
WIPO Patent Application WO/2024/071979
Kind Code:
A1
Abstract:
The present invention relates to an ophthalmic composition which comprises brimonidine or a salt thereof, SBE-β-CD or a salt thereof, and xanthan gum, is safe, and has excellent stability and therapeutic effects.
More Like This:
| JPWO2018043240 | Aqueous preparation containing 5-aminolevulinic acid |
| JP2011079861 | METHOD OF ADMINISTERING OF FGF18 |
Inventors:
LEE JOON YOUB (KR)
RYU SANG ROK (KR)
HAN BYUNG HYUN (KR)
GO HEE KYOUNG (KR)
RYU SANG ROK (KR)
HAN BYUNG HYUN (KR)
GO HEE KYOUNG (KR)
Application Number:
PCT/KR2023/014800
Publication Date:
April 04, 2024
Filing Date:
September 26, 2023
Export Citation:
Assignee:
TAEJOON PHARMACEUTICAL CO LTD (KR)
International Classes:
A61K9/08; A61K9/00; A61K31/498; A61K47/36; A61K47/40; A61P27/02; A61P27/06
Attorney, Agent or Firm:
AHN, So Young (KR)
Download PDF: